Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 04:00PM ET
215.78
Dollar change
-0.72
Percentage change
-0.33
%
IndexS&P 500 P/E43.57 EPS (ttm)4.95 Insider Own0.39% Shs Outstand84.29M Perf Week7.69%
Market Cap18.19B Forward P/E13.53 EPS next Y15.95 Insider Trans-15.31% Shs Float83.97M Perf Month7.95%
Income433.10M PEG5.08 EPS next Q3.78 Inst Own95.58% Short Float2.31% Perf Quarter6.86%
Sales12.30B P/S1.48 EPS this Y9.24% Inst Trans-2.80% Short Ratio2.73 Perf Half Y-2.70%
Book/sh94.42 P/B2.29 EPS next Y7.66% ROA2.17% Short Interest1.94M Perf Year1.50%
Cash/sh1.18 P/C183.16 EPS next 5Y8.58% ROE4.36% 52W Range191.97 - 234.09 Perf YTD-5.06%
Dividend Est.2.94 (1.36%) P/FCF26.62 EPS past 5Y-11.14% ROI3.70% 52W High-7.82% Beta1.05
Dividend TTM2.88 (1.33%) Quick Ratio0.76 Sales past 5Y2.87% Gross Margin25.90% 52W Low12.40% ATR (14)4.26
Dividend Ex-DateMay 24, 2024 Current Ratio0.88 EPS Y/Y TTM-54.91% Oper. Margin9.05% RSI (14)68.55 Volatility2.62% 2.00%
Employees67000 Debt/Eq0.75 Sales Y/Y TTM-16.64% Profit Margin3.52% Recom1.70 Target Price239.91
Option/ShortYes / Yes LT Debt/Eq0.47 EPS Q/Q12.53% Payout60.36% Rel Volume0.74 Prev Close216.50
Sales Surprise1.88% EPS Surprise5.61% Sales Q/Q-15.92% EarningsAug 01 BMO Avg Volume709.59K Price215.78
SMA205.22% SMA506.43% SMA2002.40% Trades Volume525,765 Change-0.33%
Date Action Analyst Rating Change Price Target Change
Mar-25-24Upgrade Argus Hold → Buy $250
Feb-26-24Initiated Leerink Partners Outperform $260
Feb-09-24Initiated Evercore ISI In-line $240
Jan-03-24Initiated Barclays Equal Weight $222
Sep-06-23Initiated HSBC Securities Hold $210
Dec-12-22Downgrade Citigroup Buy → Neutral $275 → $250
Sep-19-22Downgrade Argus Buy → Hold
Aug-22-22Resumed Morgan Stanley Overweight $300
Jan-28-22Downgrade Deutsche Bank Buy → Hold $330 → $294
Jan-11-21Upgrade Argus Hold → Buy $245
Jul-12-24 08:36AM
Jul-09-24 10:00AM
Jul-02-24 07:36AM
Jul-01-24 07:00AM
Jun-20-24 02:20PM
06:53AM Loading…
Jun-18-24 06:53AM
06:13AM
Jun-17-24 08:00AM
Jun-04-24 07:54AM
07:32AM
Jun-03-24 07:00AM
May-30-24 07:00AM
May-28-24 06:59AM
May-21-24 09:40AM
May-16-24 11:00AM
09:49AM Loading…
09:49AM
06:22AM
05:42AM
May-15-24 08:00AM
May-09-24 10:41AM
May-08-24 06:59AM
06:56AM
03:44AM
May-07-24 04:05PM
May-02-24 02:22AM
May-01-24 01:03AM
Apr-30-24 01:58PM
08:41AM
Apr-29-24 10:17AM
07:00AM
11:14AM Loading…
Apr-26-24 11:14AM
10:34AM
07:55AM
01:06AM
Apr-25-24 01:41PM
01:11PM
12:45PM
10:18AM
09:30AM
09:22AM
08:35AM
07:09AM
07:06AM
06:58AM
Apr-24-24 10:25PM
10:23PM
09:27PM
09:19PM
Apr-22-24 09:16AM
Apr-19-24 05:34AM
Apr-18-24 12:10PM
10:01AM
Apr-16-24 08:42AM
Apr-15-24 07:00AM
Apr-12-24 09:10AM
Apr-11-24 06:59AM
Apr-10-24 06:49AM
Apr-09-24 09:03AM
Apr-08-24 09:34AM
07:09AM
07:03AM
07:00AM
Apr-05-24 07:00AM
Apr-03-24 11:01AM
11:00AM
Apr-02-24 11:20AM
07:00AM
Apr-01-24 12:42PM
08:00AM
Mar-30-24 01:30AM
Mar-29-24 09:00AM
Mar-28-24 11:08PM
08:00AM
Mar-27-24 07:00AM
Mar-25-24 07:03AM
Mar-20-24 07:00AM
Mar-18-24 09:44AM
Mar-16-24 10:29AM
Mar-15-24 09:25AM
Mar-11-24 11:00AM
Mar-08-24 10:26AM
Mar-07-24 07:00AM
Mar-05-24 07:00AM
Feb-27-24 12:08AM
Feb-26-24 08:45AM
05:01AM
Feb-21-24 12:00PM
08:19AM
Feb-19-24 06:28AM
Feb-16-24 09:41AM
07:15AM
12:59AM
Feb-15-24 03:29PM
12:48PM
09:30AM
08:10AM
07:37AM
07:35AM
07:30AM
06:56AM
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
van der Vaart Sandra DEVP, Chief Legal OfficerMay 14 '24Sale210.832,000421,6555,637May 16 08:02 AM
ANDERSON KERRII BDirectorMay 02 '24Sale200.1025050,02515,722May 02 04:29 PM
ANDERSON KERRII BDirectorApr 30 '24Sale204.1325051,03415,972May 02 04:29 PM
Wilkinson Peter JSVP, Chief Accounting OfficerApr 29 '24Sale204.332,439498,3582,087May 01 06:29 PM
Schroeder Mark SEVP, Pres Diagnostics & COOApr 01 '24Sale217.296,4771,407,3875,036Apr 03 08:35 AM
Summy Amy B.EVP, Chief Marketing OfficerApr 01 '24Sale217.293,500760,5153,975Apr 03 08:34 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 28 '24Sale216.743,553770,0777,637Mar 29 05:54 PM
Schroeder Mark SEVP, Pres Diagnostics & COOMar 07 '24Option Exercise117.092,119248,11410,084Mar 11 08:59 AM
Schroeder Mark SEVP, Pres Diagnostics & COOMar 07 '24Sale218.455,0481,102,7365,036Mar 11 08:59 AM
Summy Amy B.EVP, Chief Marketing OfficerMar 07 '24Sale218.4522749,5883,859Mar 11 08:56 AM
EISENBERG GLENN AChief Financial Officer, EVPFeb 21 '24Option Exercise163.6314,0542,299,65658,099Feb 22 03:05 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 21 '24Sale215.9734,5047,451,86623,595Feb 22 03:05 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlFeb 21 '24Sale215.49500107,7453,401Feb 22 03:04 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 13 '24Sale226.4523753,6697,637Feb 15 08:32 AM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 08 '24Sale222.0625957,5147,637Feb 09 12:19 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 05 '24Sale220.5719342,5707,637Feb 06 03:47 PM
Wilkinson Peter JSVP, Chief Accounting OfficerNov 16 '23Sale210.711,384291,6272,087Nov 20 12:23 PM
ANDERSON KERRII BDirectorAug 08 '23Sale211.575,0001,057,83215,275Aug 10 08:55 AM